Found 7 matching trials
2nd-line Treatment of Metastatic Colorectal Cancer
PHASE2This phase 2 trial aims to evaluate the continued use of bevacizumab with r...
Location
Val d'Aurelle Cancer Institute
QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT
PHASE2The goal of this prospective, single-arm, multi-center Phase II clinical tr...
Location
Nanfang Hospital of Southern Medical University
Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer
PHASE2The purpose of this study is to evaluate the use of chemotherapy, radiation...
Location
Multiple Locations
The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer
PHASE2The study is a prospective, single-center, single-arm, two-cohort, phase II...
Location
Fudan University Shanghai Cancer Center
RALOX or CAPOX + Bevacizumab in the First-line Treatment of Advanced CRC(ROCB Study)
PHASE2Raltitrexed is an inhibitor of thymidylate synthase.As a folate antimetabol...
Location
Shenzhen People's Hospital
Modified TOMOX-HAIC in Combination With Sintilimab and Bevacizumab Biosimilar for First-line Treatment of Advanced Hepatocellular Carcinoma
PHASE2This is a single-center, single-arm, phase II clinical study, to explore th...
Location
Fudan University Shanghai Cancer Center
Survival Analysis: TACE vs. Combination Therapy in HCC
N/AThis retrospective observational study aimed to assess potential improvemen...
Location
First Affiliated Hospital, Medical College of Zhejiang University